Pradaxa Internal Bleeding and Heart Attack Lawyers
What is Pradaxa?
Pradaxa (dabigatran) is a pharmaceutical drug prescribed to treat patients with non-valvular atrial fibrillation. It is included in a class of drugs referred to as "direct thrombin inhibitors" which work by inhibiting an enzyme in the body that causes blood to cells to clot and leads to stroke. The FDA approved Pradaxa in October 2010.
Shortly after Pradaxa was approved, reports were filed with the FDA claiming that Pradaxa causes internal bleeding. No recall has yet been issued; however, the FDA did release a safety communication in December of 2011 and is investigating internal bleeding claims.
Symptoms of internal bleeding include:
- Unexpected bleeding or unusually long lasting bleeding
- Severe or uncontrollable bleeding
- Pink or brown urine
- Red or black stools
- Bruises with unknown cause
- Blood clots and coughing up blood
- Blood in vomit or vomit with "coffee grounds" consistency
- Unexpected pain, swelling, joint pain, headaches, dizziness, weakness
Other Pradaxa side effects that were reported to the FDA include gastrointestinal bleeding, heart attack, brain hemorrhaging, and death.
Click here for a timeline of events leading up to the Pradaxa lawsuit.
Our Cleveland, Ohio, dangerous and defective drug attorneys are currently investigating claims on behalf of individuals who have suffered adverse side effects after taking Pradaxa.
If you or a loved one took Pradaxa and suffered adverse side effects including internal bleeding, your injuries may have been caused by Pradaxa use. Contact a Pradaxa attorney today by filling out this contact form or by calling 1-877-696-3303, or 216-696-3232 in Cleveland.
